ERBB2 and breast cancer: Although PI3K is downstream of Her‐2 signaling, we saw many differences between mammary tumors arising in transgenic mice overexpressing Her‐2 versus PIK3CA‐H1047R, reflecting differences observed between wild‐type and mutant PI3K.